69 results on '"Newman, Jonathan A."'
Search Results
2. Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).
- Author
-
Navas-Acien, Ana, Santella, Regina M., Joubert, Bonnie R., Huang, Zhen, Lokhnygina, Yuliya, Ujueta, Francisco, Gurvich, Irina, LoIacono, Nancy J., Ravalli, Filippo, Ward, Cynthia D., Jarrett, Jeffery M., Salazar, Alfonsina De Leon, Boineau, Robin, Jones, Teresa L.Z., Mark, Daniel B., Newman, Jonathan D., Nathan, David M., Anstrom, Kevin J., and Lamas, Gervasio A.
- Abstract
The reduction in cardiovascular disease (CVD) events with edetate disodium (EDTA) in the Trial to Assess Chelation Therapy (TACT) suggested that chelation of toxic metals might provide novel opportunities to reduce CVD in patients with diabetes. Lead and cadmium are vasculotoxic metals chelated by EDTA. We present baseline characteristics for participants in TACT2, a randomized, double-masked, placebo-controlled trial designed as a replication of the TACT trial limited to patients with diabetes. TACT2 enrolled 1,000 participants with diabetes and prior myocardial infarction, age 50 years or older between September 2016 and December 2020. Among 959 participants with at least one infusion, 933 had blood and/or urine metals measured at the Centers for Diseases Control and Prevention using the same methodology as in the National Health and Nutrition Examination Survey (NHANES). We compared metal levels in TACT2 to a contemporaneous subset of NHANES participants with CVD, diabetes and other inclusion criteria similar to TACT2's participants. At baseline, the median (interquartile range, IQR) age was 67 (60, 72) years, 27% were women, 78% reported white race, mean (SD) BMI was 32.7 (6.6) kg/m
2 , 4% reported type 1 diabetes, 46.8% were treated with insulin, 22.3% with GLP1-receptor agonists or SGLT-2 inhibitors, 90.2% with aspirin, warfarin or P2Y12 inhibitors, and 86.5% with statins. Blood lead was detectable in all participants; median (IQR) was 9.19 (6.30, 13.9) µg/L. Blood and urine cadmium were detectable in 97% and median (IQR) levels were 0.28 (0.18, 0.43) µg/L and 0.30 (0.18, 0.51) µg/g creatinine, respectively. Metal levels were largely similar to those in the contemporaneous NHANES subset. TACT2 participants were characterized by high use of medication to treat CVD and diabetes and similar baseline metal levels as in the general US population. TACT2 will determine whether chelation therapy reduces the occurrence of subsequent CVD events in this high-risk population. ClinicalTrials.gov. Identifier: NCT02733185. https://clinicaltrials.gov/study/NCT02733185 [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
3. Peripheral vascular disease risk in diabetic individuals without coronary heart disease
- Author
-
Wilcox, Tanya, Newman, Jonathan D., Maldonado, Thomas S., Rockman, Caron, and Berger, Jeffrey S.
- Published
- 2018
- Full Text
- View/download PDF
4. Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.
- Author
-
Newman, Jonathan D., Anthopolos, Rebecca, Ruggles, Kelly V., Cornwell, Macintosh, Reynolds, Harmony R., Bangalore, Sripal, Mavromatis, Kreton, Held, Claes, Wallentin, Lars, Kullo, Iftikar J., McManus, Bruce, Newby, L. Kristin K., Rosenberg, Yves, Hochman, Judith S., Maron, David J., and Berger, Jeffrey S.
- Abstract
Biomarkers may improve prediction of cardiovascular events for patients with stable coronary artery disease (CAD), but their importance in addition to clinical tests of inducible ischemia and CAD severity is unknown. To evaluate the prognostic value of multiple biomarkers in stable outpatients with obstructive CAD and moderate or severe inducible ischemia. The ISCHEMIA and ISCHEMIA CKD trials randomized 5,956 participants with CAD to invasive or conservative management from July 2012 to January 2018; 1,064 participated in the biorepository. Primary outcome was cardiovascular death, myocardial infarction (MI), or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest. Secondary outcome was cardiovascular death or MI. Improvements in prediction were assessed by cause-specific hazard ratios (HR) and area under the receiver operating characteristics curve (AUC) for an interquartile increase in each biomarker, controlling for other biomarkers, in a base clinical model of risk factors, left ventricular ejection fraction (LVEF) and ischemia severity. Secondary analyses were performed among patients in whom core-lab confirmed severity of CAD was ascertained by computed cardiac tomographic angiography (CCTA). Baseline levels of interleukin-6 (IL-6), high sensitivity troponin T (hsTnT), growth differentiation factor 15 (GDF-15), N-terminal pro-B-type natriuretic peptide (NT-proBNP), lipoprotein a (Lp[a]), high sensitivity C-reactive protein (hsCRP), Cystatin C, soluble CD 40 ligand (sCD40L), myeloperoxidase (MPO), and matrix metalloproteinase 3 (MMP3). Among 757 biorepository participants, median (IQR) follow-up was 3 (2-5) years, age was 67 (61-72) years, and 144 (19%) were female; 508 had severity of CAD by CCTA available. In an adjusted multimarker model with hsTnT, GDF-15, NT-proBNP and sCD40L, the adjusted HR for the primary outcome per interquartile increase in each biomarker was 1.58 (95% CI 1.22, 2.205), 1.60 (95% CI 1.16, 2.20), 1.61 (95% 1.22, 2.14), and 1.46 (95% 1.12, 1.90), respectively. The adjusted multimarker model also improved prediction compared with the clinical model, increasing the AUC from 0.710 to 0.792 (P <.01) and 0.714 to 0.783 (P <.01) for the primary and secondary outcomes, respectively. Similar findings were observed after adjusting for core-lab confirmed atherosclerosis severity. Among ISCHEMIA biorepository participants, biomarkers of myocyte injury/distension, inflammation, and platelet activity improved cardiovascular event prediction in addition to risk factors, LVEF, and assessments of ischemia and atherosclerosis severity. These biomarkers may improve risk stratification for patients with stable CAD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry.
- Author
-
Arnold, Suzanne V., Gosch, Kensey, Kosiborod, Mikhail, Wong, Nathan D., Sperling, Laurence S., Newman, Jonathan D., Gamble, Cory L., Hamersky, Carol, Rajpura, Jigar, and Vaduganathan, Muthiah
- Abstract
Cardiovascular disease remains the primary source of morbidity and mortality in type 2 diabetes (T2D). We characterized the change over time in the use of evidence-based therapies to reduce cardiovascular risk in US patients with T2D. Data from a longitudinal outpatient diabetes registry were used to calculate the prescription of SGLT2i or GLP-1RA over time and among those with high-risk comorbidities (atherosclerotic cardiovascular disease [ASCVD], heart failure [HF], chronic kidney disease [CKD]) and a diabetes cardiovascular composite score (DCCS; calculated as: #eligible medications prescribed/#eligible medications x 100 for SGLT2i, GLP-1RA, statin, antiplatelet/anticoagulant therapy, ACEi/ARB/ARNI). Scores ranged from 0% to 100% (higher=more optimal care). Among 1,001,542 outpatients from 391 US sites, 51.7% patients had ASVCD, 17.7% HF, and 23.0% CKD. The percentage of patients prescribed an SGLT2i or GLP-1RA increased over time (7.3% in 2013 to 28.8% in 2019), and 18.3% of patients with ASCVD, HF, or CKD were on at least one of these medications at last follow-up vs 25.5% of patients without any of these comorbidities. Mean DCCS was 54±36%; 54±25% in patients with ASCVD, HF, or CKD vs 52±50% in patients without any of these comorbidities (P <0.001 for both). In a hierarchical linear model, male sex, and a diagnosis of CKD were independently associated with higher DCCS whereas a diagnosis of HF or ASCVD was associated with a lower DCCS. In a large, contemporary cohort of patients with T2D, we found improvement in the use of SGLT2i and GLP-1RA but unexpectedly lower use in patients with ASCVD, heart failure, and CKD, highlighting a treatment-risk paradox. Further education is needed to shift the understanding of these medications as tools for glucose-lowering to cardiovascular risk reduction and to improve their implementation in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Technical Measurements of Success After Peripheral Revascularization Are Not Well Correlated With Patient-centered Outcomes.
- Author
-
Ratner, Molly, Maldonado, Thomas, Cayne, Neal, Berland, Todd, Smilowitz, Nathaniel, Newman, Jonathan, Jacobowitz, Glenn, Berger, Jeffrey, and Rockman, Caron
- Published
- 2024
- Full Text
- View/download PDF
7. Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
- Author
-
Sidhu, Mandeep S., Alexander, Karen P., Huang, Zhen, Mathew, Roy O., Newman, Jonathan D., O'Brien, Sean M., Pellikka, Patricia A., Lyubarova, Radmila, Bockeria, Olga, Briguori, Carlo, Kretov, Evgeny L., Mazurek, Tomasz, Orso, Francesco, Roik, Marek F., Sajeev, Chakkanalil, Shutov, Evgeny V., Rockhold, Frank W., Borrego, David, Balter, Stephen, and Stone, Gregg W.
- Abstract
In ISCHEMIA-CKD, 777 patients with advanced chronic kidney disease and chronic coronary disease had similar all-cause mortality with either an initial invasive or conservative strategy (27.2% vs 27.8%, respectively). This prespecified secondary analysis from ISCHEMIA-CKD (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches–Chronic Kidney Disease) was conducted to determine whether an initial invasive strategy compared with a conservative strategy decreased the incidence of cardiovascular (CV) vs non-CV causes of death. Three-year cumulative incidences were calculated for the adjudicated cause of death. Overall and cause-specific death by treatment strategy were analyzed using Cox models adjusted for baseline covariates. The association between cause of death, risk factors, and treatment strategy were identified. A total of 192 of the 777 participants died during follow-up, including 94 (12.1%) of a CV cause, 59 (7.6%) of a non-CV cause, and 39 (5.0%) of an undetermined cause. The 3-year cumulative rates of CV death were similar between the invasive and conservative strategies (14.6% vs 12.6%, respectively; HR: 1.13, 95% CI: 0.75-1.70). Non-CV death rates were also similar between the invasive and conservative arms (8.4% and 8.2%, respectively; HR: 1.25; 95% CI: 0.75-2.09). Sudden cardiac death (46.8% of CV deaths) and infection (54.2% of non-CV deaths) were the most common cause-specific deaths and did not vary by treatment strategy. In ISCHEMIA-CKD, CV death was more common than non-CV or undetermined death during the 3-year follow-up. The randomized treatment assignment did not affect the cause-specific incidences of death in participants with advanced CKD and moderate or severe myocardial ischemia. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches–Chronic Kidney Disease [ISCHEMIA-CKD]; NCT01985360) [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. The trial to assess chelation therapy 2 (TACT2): Rationale and design.
- Author
-
Lamas, Gervasio A., Anstrom, Kevin J., Navas-Acien, Ana, Boineau, Robin, Kim, Hwasoon, Rosenberg, Yves, Stylianou, Mario, Jones, Teresa L.Z., Joubert, Bonnie R., Santella, Regina M., Escolar, Esteban, Aude, Y. Wady, Fonseca, Vivian, Elliott, Thomas, Lewis, Eldrin F., Farkouh, Michael E., Nathan, David M., Mon, Ana C., Gosnell, Leigh, and Newman, Jonathan D.
- Abstract
Background: Intravenous edetate disodium-based infusions reduced cardiovascular events in a prior clinical trial. The Trial to Assess Chelation Therapy 2 (TACT2) will replicate the initial study design.Methods: TACT2 is an NIH-sponsored, randomized, 2x2 factorial, double masked, placebo-controlled, multicenter clinical trial testing 40 weekly infusions of a multi-component edetate disodium (disodium ethylenediamine tetra-acetic acid, or Na2EDTA)-based chelation solution and twice daily oral, high-dose multivitamin and mineral supplements in patients with diabetes and a prior myocardial infarction (MI). TACT2 completed enrollment of 1000 subjects in December 2020, and infusions in December 2021. Subjects are followed for 2.5 to 5 years. The primary endpoint is time to first occurrence of all-cause mortality, MI, stroke, coronary revascularization, or hospitalization for unstable angina. The trial has >;85% power to detect a 30% relative reduction in the primary endpoint. TACT2 also includes a Trace Metals and Biorepository Core Lab, to test whether benefits of treatment, if present, are due to chelation of lead and cadmium from patients. Design features of TACT2 were chosen to replicate selected features of the first TACT, which demonstrated a significant reduction in cardiovascular outcomes in the EDTA chelation arm compared with placebo among patients with a prior MI, with the largest effect in patients with diabetes.Results: Results are expected in 2024.Conclusion: TACT2 may provide definitive evidence of the benefit of edetate disodiumbased chelation on cardiovascular outcomes, as well as the clinical importance of longitudinal changes in toxic metal levels of participants. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
9. Associations of a polygenic risk score with coronary artery disease phenotypes in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial.
- Author
-
Newman, Jonathan D., Douglas, Pamela S., Zhbannikov, Ilya, Ferencik, Maros, Foldyna, Borek, Hoffmann, Udo, Shah, Svati H., Ginsburg, Geoffrey S., Lu, Michael T., and Voora, Deepak
- Abstract
A polygenic risk score (PGS) is associated with obstructive coronary artery disease (CAD) independent of traditional risk factors. Coronary computed tomography angiography (CTA) can characterize coronary plaques, including features of highrisk CAD. However, it is unknown if a PGS is associated with obstructive CAD and high-risk CAD phenotypes in patients with symptoms suggestive of CAD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial.
- Author
-
Sidhu, Mandeep S., Alexander, Karen P., Huang, Zhen, O'Brien, Sean M., Chaitman, Bernard R., Stone, Gregg W., Newman, Jonathan D., Boden, William E., Maggioni, Aldo P., Steg, Philippe Gabriel, Ferguson, Thomas B., Demkow, Marcin, Peteiro, Jesus, Wander, Gurpreet S., Phaneuf, Denis C., De Belder, Mark A., Doerr, Rolf, Alexanderson-Rosas, Erick, Polanczyk, Carisi A., and Henriksen, Peter A.
- Abstract
Background: The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches trial demonstrated no overall difference in the composite primary endpoint and the secondary endpoints of cardiovascular (CV) death/myocardial infarction or all-cause mortality between an initial invasive or conservative strategy among participants with chronic coronary disease and moderate or severe myocardial ischemia. Detailed cause-specific death analyses have not been reported.Methods: We compared overall and cause-specific death rates by treatment group using Cox models with adjustment for pre-specified baseline covariates. Cause of death was adjudicated by an independent Clinical Events Committee as CV, non-CV, and undetermined. We evaluated the association of risk factors and treatment strategy with cause of death.Results: Four-year cumulative incidence rates for CV death were similar between invasive and conservative strategies (2.6% vs 3.0%; hazard ratio [HR] 0.98; 95% CI [0.70-1.38]), but non-CV death rates were higher in the invasive strategy (3.3% vs 2.1%; HR 1.45 [1.00-2.09]). Overall, 13% of deaths were attributed to undetermined causes (38/289). Fewer undetermined deaths (0.6% vs 1.3%; HR 0.48 [0.24-0.95]) and more malignancy deaths (2.0% vs 0.8%; HR 2.11 [1.23-3.60]) occurred in the invasive strategy than in the conservative strategy.Conclusions: In International Study of Comparative Health Effectiveness with Medical and Invasive Approaches, all-cause and CV death rates were similar between treatment strategies. The observation of fewer undetermined deaths and more malignancy deaths in the invasive strategy remains unexplained. These findings should be interpreted with caution in the context of prior studies and the overall trial results. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
11. CARDIOMETABOLIC RISK FACTOR BURDEN AND CIRCULATING BIOMARKERS IN PATIENTS WITH CHRONIC CORONARY DISEASE IN THE ISCHEMIA TRIALS.
- Author
-
Hamo, Carine, Newman, Jonathan D., Liu, Richard, Wu, Wenbo, Anthopolos, Rebecca, Bangalore, Sripal, Held, Claes, Kullo, Iftikhar J., Mavromatis, Kreton, McManus, Bruce M., Newby, L. Kristin, Reynolds, Harmony R., Ruggles, Kelly, Wallentin, Lars, Maron, David Joel, Hochman, Judith S., and Berger, Jeffrey S.
- Subjects
- *
CHRONICALLY ill , *BIOMARKERS , *ISCHEMIA , *MESENTERIC ischemia - Published
- 2024
- Full Text
- View/download PDF
12. Risk-sensitivity: ambient temperature affects foraging choice
- Author
-
Caraco, Thomas, Blanckenhorn, Wolf U., Gregory, Gina M., Newman, Jonathan A., Recer, Gregg M., and Zwicker, Susan M.
- Subjects
Animal behavior -- Research ,Animal heat -- Health aspects ,Animal feeding and feeds -- Research ,Juncos -- Observations ,Risk perception -- Environmental aspects ,Zoology and wildlife conservation - Published
- 1990
13. Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review.
- Author
-
Newman, Jonathan D., Bhatt, Deepak L., Rajagopalan, Sanjay, Balmes, John R., Brauer, Michael, Breysse, Patrick N., Brown, Alison G.M., Carnethon, Mercedes R., Cascio, Wayne E., Collman, Gwen W., Fine, Lawrence J., Hansel, Nadia N., Hernandez, Adrian, Hochman, Judith S., Jerrett, Michael, Joubert, Bonnie R., Kaufman, Joel D., Malik, Ali O., Mensah, George A., and Newby, David E.
- Subjects
- *
AIR pollution , *DISEASE risk factors , *CLINICAL trials , *INTERNATIONAL agencies , *PARTICULATE matter , *LUNG disease prevention , *PREVENTION of heart diseases , *EDUCATION , *LUNG diseases , *SOCIAL networks , *PSYCHOLOGICAL tests , *IMPACT of Event Scale , *RESEARCH funding , *QUESTIONNAIRES , *HEART diseases - Abstract
Fine particulate air pollution <2.5 μm in diameter (PM2.5) is a major environmental threat to global public health. Multiple national and international medical and governmental organizations have recognized PM2.5 as a risk factor for cardiopulmonary diseases. A growing body of evidence indicates that several personal-level approaches that reduce exposures to PM2.5 can lead to improvements in health endpoints. Novel and forward-thinking strategies including randomized clinical trials are important to validate key aspects (e.g., feasibility, efficacy, health benefits, risks, burden, costs) of the various protective interventions, in particular among real-world susceptible and vulnerable populations. This paper summarizes the discussions and conclusions from an expert workshop, Reducing the Cardiopulmonary Impact of Particulate Matter Air Pollution in High Risk Populations, held on May 29 to 30, 2019, and convened by the National Institutes of Health, the U.S. Environmental Protection Agency, and the U.S. Centers for Disease Control and Prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review.
- Author
-
Newman, Jonathan D, Vani, Anish K, Aleman, Jose O, Weintraub, Howard S, Berger, Jeffrey S, and Schwartzbard, Arthur Z
- Abstract
Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Despite improved risk factor control, however, adults with T2D continue to experience substantial excess CVD risk. Until recently, however, improved glycemic control has not been associated with robust macrovascular benefit. The advent of 2 new classes of antihyperglycemic agents, the sodium-glucose cotransporter-2 inhibitors and the glucagon-like peptide-1 receptor agonists, and their respective large cardiovascular outcome trials, has led to a paradigm shift in how cardiologists and heath care practitioners conceptualize T2D treatment. Herein, the authors review the recent trial evidence, the potential mechanisms of action of the sodium-glucose cotransporter-2 inhibitors and the glucagon-like peptide-1 receptor agonists, safety concerns, and their use for the primary prevention of CVD as well as in diabetic patients with impaired renal function and heart failure. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
15. Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial.
- Author
-
Gianos, Eugenia, Schoenthaler, Antoinette, Guo, Yu, Zhong, Judy, Weintraub, Howard, Schwartzbard, Arthur, Underberg, James, Schloss, Michael, Newman, Jonathan D., Heffron, Sean, Fisher, Edward A., and Berger, Jeffrey S.
- Abstract
Background: Patients undergoing cardiovascular (CV) procedures often have suboptimal CV risk factor control and may benefit from strategies targeting healthy lifestyle behaviors and education. Implementation of prevention strategies may be particularly effective at this point of heightened motivation.Methods: A prospective, randomized, pilot study was conducted in 400 patients undergoing a nonurgent CV procedure (cardiac catheterization ± revascularization) to evaluate the impact of different prevention strategies. Patients were randomized in a 1:1:1 fashion to usual care (UC; group A, n = 134), in-hospital CV prevention consult (PC; group B, n = 130), or PC plus behavioral intervention program (telephone-based motivational interviewing and optional tailored text messages) (group C, n = 133). The primary end point was the Δ change in non-high-density lipoprotein cholesterol (non-HDL-C) from baseline to 6 month.Results: The mean age was 64.6 ± 10.8 years, 23.7% were female, and 31.5% were nonwhite. After 6 months, the absolute difference in non-HDL-C for all participants was -19.8 mg/dL (95% CI -24.1 to -15.6, P < .001). There were no between-group differences in the primary end point for the combined PC groups (B and C) versus UC, with a Δ adjusted between group difference of -5.5 mg/dL (95% CI -13.1 to 2.1, P = .16). Patients in the PC groups were more likely to be on high-intensity statins at 6 months (52.9% vs 38.1%, P = .01). After excluding participants with baseline non-HDL-C <100 mg/dL (initial exclusion criterion), Δ non-HDL-C and Δ low-density lipoprotein cholesterol were improved in the PC groups compared to UC (non-HDL-C -8.13 mg/dL [-16.00 to -0.27], P = .04; low-density lipoprotein cholesterol -7.87mg/dL [-15.10 to -0.64], P = .03).Conclusions: Although non-HDL-C reduction at 6 months following a nonurgent CV procedure was not significant in the overall cohort, an increased uptake in high-potency statins may translate into improved long-term health outcomes and cost reductions. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
16. Current and potential future distribution of the American dog tick (Dermacentor variabilis, Say) in North America.
- Author
-
Minigan, Jordan N., Hager, Heather A., Peregrine, Andrew S., and Newman, Jonathan A.
- Abstract
The American dog tick ( Dermacentor variabilis ) is medically and economically important in North America. This species is found across central and eastern North America from the Gulf Coast of Mexico through southern Canada. In parts of this region, D. variabilis is a vector for pathogens that cause diseases in humans and animals. Our aim was to determine whether climate change would affect the distribution of the climatically suitable area for D. variabilis in North America, to aid monitoring for potential future spread of tick-borne pathogens. We developed a species distribution model for D. variabilis to project where climate will likely be suitable for the tick in North America using a maximum entropy method, occurrence records from museum and laboratory archives, and 10 environmental variables relevant to climate requirements for the tick. We used four emissions scenarios from the Intergovernmental Panel on Climate Change's Fifth Assessment Report and 10 climate models from the Coupled Model Intercomparison Project (phase 5) to estimate potential future climate suitability and determine how the tick's distribution could change. Our consensus model projected that the area of suitable climate in North America could increase from present by approximately 50% by 2070. In areas beyond the current northern limit of D. variabilis , climate could become more suitable for the tick than at present, possibly resulting in a northward expansion in Canada, but the potential suitability of the southern range of D. variabilis could decrease, depending on the region and climate model. Due to the ability of D. variabilis to harbor and transmit pathogens, a change in the distribution of this species could also affect the risk of human and animal diseases throughout North America, particularly in the northern range of the tick. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
17. Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
- Author
-
Newman, Jonathan D., Schwartzbard, Arthur Z., Weintraub, Howard S., Goldberg, Ira J., and Berger, Jeffrey S.
- Subjects
- *
CARDIOVASCULAR disease prevention , *TYPE 2 diabetes , *CAUSES of death , *BLOOD pressure , *GLYCEMIC control , *BODY mass index - Abstract
Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with T2D meet recommended guidelines for CVD prevention. The burden of T2D is increasing: by 2050, approximately 1 in 3 U.S. individuals may have T2D, and patients with T2D will comprise an increasingly large proportion of the CVD population. The authors believe it is imperative that we expand the use of therapies proven to reduce CVD risk in patients with T2D. The authors summarize evidence and guidelines for lifestyle (exercise, nutrition, and weight management) and CVD risk factor (blood pressure, cholesterol and blood lipids, glycemic control, and the use of aspirin) management for the prevention of CVD among patients with T2D. The authors believe appropriate lifestyle and CVD risk factor management has the potential to significantly reduce the burden of CVD among patients with T2D. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
18. Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease.
- Author
-
Newman, Jonathan D., Rockman, Caron B., Kosiborod, Mikhail, Guo, Yu, Zhong, Hua, Weintraub, Howard S., Schwartzbard, Arthur Z., Adelman, Mark A., and Berger, Jeffrey S.
- Abstract
Diabetes mellitus (diabetes) is associated with significantly increased risk of peripheral vascular disease. Diabetes is classified as a coronary heart disease (CHD) risk equivalent, but it is unknown whether diabetes is a CHD risk equivalent for peripheral vascular disease. The objective was to evaluate the odds of peripheral arterial disease (PAD) or carotid artery stenosis (CAS) among participants with diabetes, CHD, or both, compared with participants without diabetes or CHD, in a nationwide vascular screening database. We hypothesized that diabetes and CHD would confer similar odds of PAD and CAS.
Methods: A cross-sectional analysis of all eligible Life Line Screening Inc participants age 30 to 90 years with ankle brachial indices for PAD (ankle brachial index <0.9 in either leg) and carotid artery duplex ultrasonographic imaging for CAS (internal CAS ≥50%) was performed (N=3,522,890).Results: Diabetes and CHD were present in 372,330 (10.7%) and 182,760 (5.8%) of participants, respectively; PAD and CAS were present in 155,000 (4.4%) and 130,347 (3.7%) of participants. After multivariable adjustment, PAD odds were 1.56 (95% CI 1.54-1.59) and 1.69 (95% CI 1.65-1.73) for participants with diabetes or CHD, respectively. Participants with both diabetes and CHD had 2.75-fold increased odds of PAD (95% CI 2.66-2.85). Findings were similar for CAS; compared with no diabetes or CHD, CAS odds increased for participants with diabetes alone (1.53, 95% CI 1.50-1.56), CHD alone (1.72, 95% CI 1.68-1.76), and both diabetes and CHD (2.57, 95% CI 2.49-2.66). Findings were consistent for women and men.Conclusion: In a large database of more than 3.5 million self-referred participants, diabetes was a CHD risk equivalent for PAD and CAS, and participants with comorbid diabetes and CHD had an especially robust association with PAD and CAS. Counseling regarding screening and prevention of peripheral vascular disease may be useful for patients with diabetes. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
19. Foraging, predation hazard and patch use in grey squirrels
- Author
-
Newman, Jonathan A. and Caraco, Thomas
- Subjects
Predation (Biology) -- Research ,Animals -- Food and nutrition ,Gray squirrel -- Behavior ,Zoology and wildlife conservation - Published
- 1987
20. Social experience and the formation of dominance relationships in the pumpkinseed sunfish, Lepomis gibbosus
- Author
-
Beacham, Jeffery L. and Newman, Jonathan A.
- Subjects
Sunfishes -- Behavior ,Social hierarchy in animals -- Research ,Zoology and wildlife conservation - Published
- 1987
21. Metal pollutants and cardiovascular disease: Mechanisms and consequences of exposure.
- Author
-
Solenkova, Natalia V., Newman, Jonathan D., Berger, Jeffrey S., Thurston, George, Hochman, Judith S., and Lamas, Gervasio A.
- Abstract
Introduction There is epidemiological evidence that metal contaminants may play a role in the development of atherosclerosis and its complications. Moreover, a recent clinical trial of a metal chelator had a surprisingly positive result in reducing cardiovascular events in a secondary prevention population, strengthening the link between metal exposure and cardiovascular disease (CVD). This is, therefore, an opportune moment to review evidence that exposure to metal pollutants, such as arsenic, lead, cadmium, and mercury, is a significant risk factor for CVD. Methods We reviewed the English-speaking medical literature to assess and present the epidemiological evidence that 4 metals having no role in the human body (xenobiotic), mercury, lead, cadmium, and arsenic, have epidemiologic and mechanistic links to atherosclerosis and CVD. Moreover, we briefly review how the results of the Trial to Assess Chelation Therapy (TACT) strengthen the link between atherosclerosis and xenobiotic metal contamination in humans. Conclusions There is strong evidence that xenobiotic metal contamination is linked to atherosclerotic disease and is a modifiable risk factor. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
22. Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk.
- Author
-
Ye, Siqin, Wang, Y. Claire, Shimbo, Daichi, Newman, Jonathan D., Levitan, Emily B., and Muntner, Paul
- Abstract
Abstract: Systolic blood pressure (SBP) often varies between clinic visits within individuals, which can affect estimation of cardiovascular disease (CVD) risk. We analyzed data from participants with two clinic visits separated by a median of 17 days in the Third National Health and Nutrition Examination Survey (n = 808). Ten-year CVD risk was calculated with SBP obtained at each visit using the Pooled Cohort Equations. The mean age of participants was 46.1 years, and 47.3% were male. The median SBP difference between the two visits was −1 mm Hg (1st to 99th percentiles: −23 to 32 mm Hg). The median estimated 10-year CVD risk was 2.5% and 2.4% at the first and second visit, respectively (1st to 99th percentiles −5.2% to +7.1%). Meaningful risk reclassification (ie, across the guideline recommended 7.5% threshold for statin initiation) occurred in 12 (11.3%) of 106 participants whose estimated CVD risk was between 5% and 10%, but only in two (0.3%) of 702 participants who had a 10-year estimated CVD risk of <5% or >10%. SBP variability can affect CVD risk estimation, and can influence statin eligibility for individuals with an estimated 10-year CVD risk between 5% and 10%. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
23. Trends in Myocardial Infarction Rates and Case Fatality by Anatomical Location in Four United States Communities, 1987 to 2008 (from the Atherosclerosis Risk in Communities Study).
- Author
-
Newman, Jonathan D., Shimbo, Daichi, Baggett, Chris, Xiaoxi Liu, Crow, Richard, Abraham, JoEllyn M., Loehr, Laura R., Wruck, Lisa M., Folsom, Aaron R., and Rosamond, Wayne D.
- Subjects
- *
MYOCARDIAL infarction , *DISEASE incidence , *ATHEROSCLEROSIS risk factors , *PUBLIC health , *ELECTROCARDIOGRAPHY , *HOSPITAL records - Abstract
Although the incidence of and mortality after ST-segment elevation myocardial infarction (STEMI) is decreasing, time trends in anatomical location of STEMI and associated shortterm prognosis have not been examined in a population-based community study. We determined 22-year trends in age- and race-adjusted gender-specific incidences and 28-day case fatality of hospitalized STEMI by anatomic infarct location among a stratified random sample of 35- to 74-year-old residents of 4 communities in the Atherosclerosis Risk in Communities study. STEMI infarct location was assessed by 12-lead electrocardiograms from the hospital record and was coded as anterior, inferior, lateral, and multilocation STEMIs using the Minnesota code. From 1987 to 2008, a total of 4,845 patients had an incident STEMI; 37.2% were inferior STEMI, 32.8% were anterior, 16.8% occurred in multiple infarct locations, and 13.2% were lateral STEMI. For inferior, anterior, and lateral STEMIs in both men and women, significant decreases were observed in the age-adjusted annual incidence and the associated 28-day case fatality. In contrast, for STEMI in multiple infarct locations, neither the annual incidence nor the 28-day case fatality changed over time. The age- and race-adjusted annual incidence and associated 28-day case fatality of STEMI in anterior, inferior, and lateral infarct locations decreased during 22 years of surveillance; however, no decrease was observed for STEMI in multiple infarct locations. In conclusion, our findings suggest that there is room for improvement in the care of patients with multilocation STEMI. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
24. Relation of Patients Living Without a Partner or Spouse to Being Physically Active After Acute Coronary Syndromes (from the PULSE Accelerometry Substudy).
- Author
-
Green, Philip, Newman, Jonathan D., Shaffer, Jonathan A., Davidson, Karina W., Maurer, Mathew S., and Schwartz, Joseph E.
- Subjects
- *
ACUTE coronary syndrome , *PHYSICAL activity , *HOSPITAL care , *ACCELEROMETERS , *HEART diseases - Abstract
Living alone is associated with adverse outcomes after acute coronary syndromes (ACS). One potential mediator of the relation between partner status and outcomes after ACS is physical activity. To evaluate the association of partner status with physical activity after ACS, data from 107 participants enrolled in the Prescription Use, Lifestyle, and Stress Evaluation (PULSE) study, a prospective observational study of post-ACS patients, were analyzed. Accelerometers were used to measure physical activity after hospital discharge. The primary outcome measure was a maximum 10 hours of daytime activity 1 month after discharge. One month after discharge from ACS hospitalizations, participants without a partner or spouse exhibited 24.4% lower daytime activity than those with a partner or spouse (p = 0.003). After controlling for age, gender, body mass index, Charlson co-morbidity index, and traditional psychosocial and clinical cardiovascular correlates of post-ACS physical activity, partner status remained an independent predictor of post-ACS physical activity (20.5% lower daytime activity among those without a partner or spouse, p = 0.008). In conclusion, in this study of accelerometer-measured physical activity after an ACS hospitalization, those without a partner or spouse exhibit significantly less physical activity than those with a partner or spouse 1 month after discharge from the hospital. Low physical activity may be an important mediator of the prognosis associated with partner status after ACS. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
25. Gender Differences in Calls to 9-1-1 During an Acute Coronary Syndrome.
- Author
-
Newman, Jonathan D., Davidson, Karina W., Ye, Siqin, Shaffer, Jonathan A., Shimbo, Daichi, and Muntner, Paul
- Subjects
- *
GENDER differences (Psychology) , *TREATMENT of acute coronary syndrome , *ACUTE coronary syndrome , *CONFIDENCE intervals , *SELF-evaluation , *ANGINA pectoris , *PROGNOSIS - Abstract
Calling 911 during acute coronary syndromes (ACS) decreases time to treatment and may improve prognosis. Women may have more atypical ACS symptoms compared to men, but few data are available on differences in gender and ACS symptoms in calling 911. In this study, patient interviews and structured chart reviews were conducted to determine gender differences in calling 911. Calls to 911 were assessed by self-report and validated by medical chart review. Of the 476 patients studied, 292 (61%) were diagnosed with unstable angina and 184 (39%) with myocardial infarctions (MIs). Overall, only 23% of patients called 911. Similar percentages of women and men with unstable angina called 911 (15% and 13%, respectively, p = 0.59). In contrast, women with MIs were significantly more likely to call 911 than men (57% vs 28%, p <0.001). After adjustment for sociodemographic factors, health insurance status, history of MI, the left ventricular ejection fraction, Global Registry of Acute Coronary Events (GRACE) score, and ACS symptoms, women were 1.79 times more likely to call 911 during an MI than men (prevalence ratio 1.79, 95% confidence interval 1.22 to 2.64, p <0.01). In conclusion, the findings of the present study suggest that initiatives to increase calls to 911 are needed for women and men. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
26. Diet Selection: An Interdisciplinary Approach to Foraging Behaviour
- Author
-
Newman, Jonathan A.
- Subjects
Diet Selection: An Interdisciplinary Approach to Foraging Behaviour (Book) -- Book reviews ,Books -- Book reviews ,Zoology and wildlife conservation - Published
- 1994
27. Prevalence and persistence of foreign DNA beneath fingernails.
- Author
-
Matte, Melinda, Williams, Linda, Frappier, Roger, and Newman, Jonathan
- Subjects
FINGERNAILS ,DNA analysis ,DNA fingerprinting ,FORENSIC sciences ,DNA data banks ,FORENSIC genetics - Abstract
Abstract: Fingernail scrapings and clippings are routinely examined for the presence of foreign DNA profiles in forensic casework where the case history suggests their evidentiary relevance. In order to better understand the significance of these findings, casework results from the Centre of Forensic Sciences (CFS) were analyzed and several controlled studies were conducted. In an analysis of casework data (n =265), 33% of fingernail samples contained a foreign source of DNA, 63% of which were detected at 5 or more STR loci. In a sampling of fingernails from the general population (n =178), 19% contained a foreign source of DNA, 35% of which were detected at 5 or more STR loci. In a study involving deliberate scratching of another individual (n =30), 33% of individuals had a foreign DNA profile beneath their fingernails from which the person they scratched could not be excluded as the source; however when sampling occurred ∼6h after the scratching event, only 7% retained the foreign DNA. This research suggests the incidence of foreign DNA profiles beneath fingernails in the general population is low but, when present, the majority is of limited significance and tends not to persist for an extensive period of time. These data are provided to assist the forensic analyst when providing his or her opinion as to the relevance of foreign DNA present under fingernails. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
28. Observed Hostility and the Risk of Incident Ischemic Heart Disease: A Prospective Population Study From the 1995 Canadian Nova Scotia Health Survey
- Author
-
Newman, Jonathan D., Davidson, Karina W., Shaffer, Jonathan A., Schwartz, Joseph E., Chaplin, William, Kirkland, Susan, and Shimbo, Daichi
- Subjects
- *
HOSTILITY , *CORONARY heart disease risk factors , *LONGITUDINAL method , *CARDIOVASCULAR diseases , *HEALTH surveys , *MENTAL depression , *FOLLOW-up studies (Medicine) - Abstract
Objectives: The aim of this study was to examine the relation between hostility and incident ischemic heart disease (IHD) and to determine whether observed hostility is superior to patient-reported hostility for the prediction of IHD in a large, prospective observational study. Background: Some studies have found that hostile patients have an increased risk of incident IHD. However, no studies have compared methods of hostility assessment or considered important psychosocial and cardiovascular risk factors as confounders. Furthermore, it is unknown whether all expressions of hostility carry equal risk or whether certain manifestations are more cardiotoxic. Methods: We assessed the independent relationship between baseline observed hostility and 10-year incident IHD in 1,749 adults of the population-based Canadian Nova Scotia Health Survey. Results: There were 149 (8.5%) incident IHD events (140 nonfatal, 9 fatal) during the 15,295 person-years of observation (9.74 events/1,000 person-years). Participants with any observed hostility had a greater risk of incident IHD than those without (p = 0.02); no such relation was found for patient-reported hostility. Those with any observed hostility had a significantly greater risk of incident IHD (hazard ratio: 2.06, 95% confidence interval: 1.04 to 4.08, p = 0.04), after adjusting for cardiovascular (age, sex, Framingham Risk Score) and psychosocial (depression, positive affect, patient-reported hostility, and anger) risk factors. Conclusions: The presence of any observed hostility at baseline was associated with a 2-fold increased risk of incident IHD over 10 years of follow-up. Compared with patient-reported measures, observed hostility is a superior predictor of IHD. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
29. Racial and Ethnic Disparity in Cardiovascular Risk Factor Control in Patients Presenting for Elective Catheterization*.
- Author
-
Rudy, Hayeem, Levy, Andrew, Vani, Anish, Balakrishnan, Reva, Guo, Yu, Newman, Jonathan, Wentraub, Howard, Schwartzbard, Arthur, Fisher, Edward, Underberg, James, Berger, Jeffrey, and Gianos, Eugenia
- Subjects
CARDIOVASCULAR diseases risk factors ,CATHETERIZATION ,RACE - Published
- 2015
- Full Text
- View/download PDF
30. MANAGEMENT AND OUTCOMES OF PATIENTS WITH DIABETES MELLITUS (DM) AND STABLE ISCHEMIC HEART DISEASE (SIHD): POOLED DATA FROM THE ISCHEMIA AND ISCHEMIA-CKD TRIALS.
- Author
-
Newman, Jonathan, Anthopolos, Rebecca, Mancini, G.B. John, Bangalore, Sripal, Reynolds, Harmony, Senior, Roxy, Peteiro, Jesus, Bhargava, Balram, Garg, Pallav, Escobedo, Jorge, Doerr, Rolf, Mazurek, Tomasz, Oomman, Abraham, Gonzalez-Juanatey, Jose, Gajos, Grzegorz, Sharir, Tali, Keltai, Matyas, Maggioni, Aldo Pietro, Stone, Gregg, and Berger, Jeffrey
- Subjects
- *
CORONARY disease , *DIABETES , *PEOPLE with diabetes , *ISCHEMIA - Published
- 2021
- Full Text
- View/download PDF
31. Increasing DER integration through discrete intraday settlements.
- Author
-
Newman, Jonathan and MacDougall, Pamela
- Subjects
- *
INDEPENDENT system operators , *POWER resources , *EFFICIENT market theory , *SYSTEM integration , *MONETARY incentives , *MARKET design & structure (Economics) , *LIQUID-liquid extraction - Abstract
• U.S. wholesale RTO/ISO markets must be refined to leverage growing DER presence. • DER forecast errors decline as information improves in final hours before dispatch. • Intraday markets provide financial incentives to correct forecasts more efficiently. • Intermediate auctions incorporate principles of U.S. centralized dispatch. • U.S. RTOs/ISOs should adopt intermediate auctions to support DER integration. Deployment of distributed energy resources (DERs) is accelerating across the United States. These assets have the potential to provide cost-effective grid services and bulk power while supporting a low-cost energy transition to carbon-free electricity. Full integration of these resources into the bulk power system remains a barrier to unlocking the potential value of these assets. The regional wholesale energy markets, originally designed to integrate centralized, dispatchable power plants, must be reformed to adapt to the changing potential resource mix. The current day-ahead and real-time system is poorly designed for DERs. Day-ahead DER forecast errors create exposure to real-time price variations, as resources committed in the day-ahead market are required to rebalance in real-time, challenging the business model for DERs. New intraday markets with multiple discrete intermediate auctions between the day-ahead market and real-time market are needed to enable proper integration of DERs and efficient mitigation of forecast uncertainty risk. These markets must incorporate financially-binding commitments, closer-to-dispatch price signals, and adequate liquidity to ensure competition. Intermediate auctions should be built on top of existing intraday processes in each regional market, incorporating the principles of the existing market structures and leveraging the benefits of the centralized dispatch systems. Regional transmission organization (RTOs) and Independent System Operators (ISOs) should pursue and implement intermediate auctions to support fair, open, and efficient markets in the U.S. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) Trial Attainment of National Lipid Association Guideline (NLA) Goals.
- Author
-
Mathews, Tony, Berger, Jeffrey, Weintraub, Howard, Schwartzbard, Arthur, Underberg, James, Newman, Jonathan, Heffron, Sean, Schoenthaler, Antoinette, Fisher, Edward, and Gianos, Eugenia
- Published
- 2017
- Full Text
- View/download PDF
33. A NOVEL GENE EXPRESSION SIGNATURE PREDICTIVE OF OUTCOMES IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE.
- Author
-
Newman, Jonathan D., Ruggles, Kelly, Zhou, Hua, Rockman, Caron, Heguy, Adriana, Suarez, Yajaira, Hochman, Judith, and Berger, Jeffrey
- Subjects
- *
PERIPHERAL vascular diseases , *GENE expression - Published
- 2019
- Full Text
- View/download PDF
34. THE ASSOCIATION BETWEEN AIR POLLUTION AND IN-HOSPITAL MYOCARDIAL INFARCTION OUTCOMES IN A NATIONWIDE DATASET.
- Author
-
Bonanni, Luke, Smilowitz, Nathaniel Rosso, and Newman, Jonathan D.
- Subjects
- *
AIR pollution , *MYOCARDIAL infarction - Published
- 2024
- Full Text
- View/download PDF
35. Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.
- Author
-
Arnold, Suzanne V., Jones, Philip G., Maron, David J., Cohen, David J., Mark, Daniel B., Reynolds, Harmony R., Bangalore, Sripal, Chen, Jiyan, Newman, Jonathan D., Harrington, Robert A., Stone, Gregg W., Hochman, Judith S., and Spertus, John A.
- Subjects
- *
CORONARY disease , *CHRONIC diseases , *PARSIMONIOUS models , *ANGINA pectoris , *CHRONICALLY ill - Abstract
The ISCHEMIA trial found that patients with chronic coronary disease randomized to invasive strategy had better health status than those randomized to conservative strategy. It is unclear how best to translate these population-level results to individual patients. The authors sought to identify patient characteristics associated with health status from invasive and conservative strategies, and develop a prediction algorithm for shared decision-making. One-year disease-specific health status was assessed in ISCHEMIA with the Seattle Angina Questionnaire (SAQ) Summary Score (SAQ SS) and Angina Frequency, Physical Limitations (PL), and Quality of Life (QL) domains (range 0-100, higher = less angina/better health status). Among 4,617 patients from 320 sites in 37 countries, mean SAQ SS was 74.1 ± 18.9 at baseline and 85.7 ± 15.6 at 1 year. Lower baseline SAQ SS and younger age were associated with better 1-year health status with invasive strategy (P interaction = 0.009 and P interaction = 0.004, respectively). For the individual domains, there were significant treatment interactions for baseline SAQ score (Angina Frequency, PL), age (PL, QL), anterior ischemia (PL), and number of baseline antianginal medications (QL), with more benefit of invasive in patients with worse baseline health status, younger age, anterior ischemia, and on more antianginal medications. Parsimonious prediction models were developed for 1-year SAQ domains with invasive or conservative strategies to support shared decision-making. In the management of chronic coronary disease, individual patient characteristics are associated with 1-year health status, with younger age and poorer angina-related health status showing greater benefit from invasive management. This prediction algorithm can support the translation of the ISCHEMIA trial results to individual patients. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522) [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. PREDICTORS OF LDL-CHOLESTEROL AND SYSTOLIC BLOOD PRESSURE (SBP) GOAL ATTAINMENT AT ONE YEAR: INTERIM DATA FROM THE ISCHEMIA TRIAL.
- Author
-
Newman, Jonathan D., Alexander, Karen, O’Brien, Sean, Gu, Xiangqiong, Govindan, Sajeev, Senior, Roxy, Rezende, Paulo, Moorthy, Nagaraja, Demkow, Marcin, Lopez-Sendon, Jose, Bockeria, Olga, Gosselin, Gilbert, Pandit, Neeraj, Stone, Peter, Boden, William, Spertus, John, Stone, Gregg, Hochman, Judith, and Maron, David
- Published
- 2018
- Full Text
- View/download PDF
37. PERIPHERAL VASCULAR DISEASE RISK EQUIVALENCE IN DIABETES DEPENDS ON CONCOMITANT RISK FACTORS.
- Author
-
Wilcox, Tanya, Newman, Jonathan, and Berger, Jeffrey
- Published
- 2018
- Full Text
- View/download PDF
38. MISSED OPPORTUNITIES FOR CARDIOVASCULAR DISEASE (CVD) PREVENTION DURING US AMBULATORY CARE VISITS FOR PATIENTS WITH DIABETES MELLITUS.
- Author
-
Newman, Jonathan D., Berger, Jeffrey, and Ladapo, Joseph
- Published
- 2018
- Full Text
- View/download PDF
39. Particulate Air Pollution and Carotid Artery Stenosis.
- Author
-
Newman, Jonathan D., Thurston, George D., Cromar, Kevin, Yu Guo, Rockman, Caron B., Fisher, Edward A., and Berger, Jeffrey S.
- Subjects
- *
CORONARY disease , *STROKE , *HEMODYNAMICS ,PARTICULATE matter & the environment ,CAROTID artery stenosis - Published
- 2015
- Full Text
- View/download PDF
40. Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review.
- Author
-
Mechanick, Jeffrey I., Farkouh, Michael E., Newman, Jonathan D., and Garvey, W. Timothy
- Subjects
- *
CHRONIC diseases , *ATRIAL fibrillation , *CARDIOVASCULAR diseases , *CORONARY disease , *HEART diseases , *PREVENTION of chronic diseases , *CARDIOVASCULAR disease prevention , *PREVENTIVE health services , *ANIMALS - Abstract
In the second part of this JACC State-of-the-Art Review, an early and sustainable preventive care plan is described for cardiometabolic-based chronic disease. This plan can improve cardiometabolic health by targeting early mechanistic events to decrease the risk for certain cardiovascular diseases (e.g., coronary heart disease, heart failure, and atrial fibrillation). Included are various prevention modalities, intensive lifestyle interventions, pharmacotherapy and cardiovascular outcome trial evidence, and bariatric/metabolic procedures. A tactical approach of implementing published clinical practice guidelines/algorithms for early behavioral, adiposity, and dysglycemia targeting is emphasized, as well as relevant educational and research implications. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
41. Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review.
- Author
-
Mechanick, Jeffrey I., Farkouh, Michael E., Newman, Jonathan D., and Garvey, W. Timothy
- Subjects
- *
CHRONIC diseases , *OBESITY , *CARDIOVASCULAR diseases , *ATRIAL fibrillation , *CARDIOVASCULAR disease prevention , *ADIPOSE tissues , *GLUCOSE metabolism disorders , *DISEASE complications - Abstract
A new cardiometabolic-based chronic disease (CMBCD) model is presented that provides a basis for early and sustainable, evidence-based therapeutic targeting to promote cardiometabolic health and mitigate the development and ravages of cardiovascular disease. In the first part of this JACC State-of-the-Art Review, a framework is presented for CMBCD, focusing on 3 primary drivers (genetics, environment, and behavior) and 2 metabolic drivers (adiposity and dysglycemia) with applications to 3 cardiovascular endpoints (coronary heart disease, heart failure, and atrial fibrillation). Specific mechanistic pathways are presented configuring early primary drivers with subsequent adiposity, insulin resistance, β-cell dysfunction, and metabolic syndrome, leading to cardiovascular disease. The context for building this CMBCD model is to expose actionable targets for prevention to achieve optimal cardiovascular outcomes. The tactical implementation of this CMBCD model is the subject of second part of this JACC State-of-the-Art Review. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
42. DIABETES MELLITUS IS A CARDIOVASCULAR DISEASE (CVD) RISK EQUIVALENT FOR PERIPHERAL ARTERIAL DISEASE AND CAROTID ARTERY STENOSIS.
- Author
-
Newman, Jonathan, Berger, Jeffrey, Rockman, Caron, Guo, Yu, Weintraub, Howard, Schwartzbard, Arthur, Kosiborod, Mikhail, and Adelman, Mark
- Subjects
- *
CARDIOVASCULAR disease diagnosis , *DIABETES risk factors , *ARTERIAL diseases , *FAMILY history (Medicine) , *CARDIAC imaging , *DISEASE prevalence , *MEDICAL screening ,CAROTID artery stenosis - Published
- 2016
- Full Text
- View/download PDF
43. GEOGRAPHICAL VARIATION IN ISCHEMIA SEVERITY IN PATIENTS REFERRED FOR STRESS IMAGING STUDIES: SCREENING DATA FROM THE ISCHEMIA TRIAL.
- Author
-
Jeffrey, Berger S., Newman, Jonathan D., Gregoire, Jean, Senior, Roxy, Demkow, Marcin, Phaneuf, Denis, Vertes, Andras, Escobedo, Jorge, Kedev, Sasko, Mortara, Andrea, Dauber, Ira M., Monti, Lorenzo, Devlin, Gerard, Cha, James, Stone, Peter, Reynolds, Harmony R., Johnston, Nicola, Gajos, Grzegorz, Mavromatis, Kreton, and Lopez-Sendon, Jose Luis
- Published
- 2014
- Full Text
- View/download PDF
44. Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.
- Author
-
Nguyen, Dan D., Spertus, John A., Alexander, Karen P., Newman, Jonathan D., Dodson, John A., Jones, Philip G., Stevens, Susanna R., O'Brien, Sean M., Gamma, Reto, Perna, Gian P., Garg, Pallav, Vitola, João V., Chow, Benjamin J.W., Vertes, Andras, White, Harvey D., Smanio, Paola E.P., Senior, Roxy, Held, Claes, Li, Jianghao, and Boden, William E.
- Subjects
- *
HEART failure , *OLDER people , *CORONARY disease , *AGE differences , *PROPORTIONAL hazards models , *TREATMENT effectiveness - Abstract
Whether initial invasive management in older vs younger adults with chronic coronary disease and moderate or severe ischemia improves health status or clinical outcomes is unknown. The goal of this study was to examine the impact of age on health status and clinical outcomes with invasive vs conservative management in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial. One-year angina-specific health status was assessed with the 7-item Seattle Angina Questionnaire (SAQ) (score range 0-100; higher scores indicate better health status). Cox proportional hazards models estimated the treatment effect of invasive vs conservative management as a function of age on the composite clinical outcome of cardiovascular death, myocardial infarction, or hospitalization for resuscitated cardiac arrest, unstable angina, or heart failure. Among 4,617 participants, 2,239 (48.5%) were aged <65 years, 1,713 (37.1%) were aged 65 to 74 years, and 665 (14.4%) were aged ≥75 years. Baseline SAQ summary scores were lower in participants aged <65 years. Fully adjusted differences in 1-year SAQ summary scores (invasive minus conservative) were 4.90 (95% CI: 3.56-6.24) at age 55 years, 3.48 (95% CI: 2.40-4.57) at age 65 years, and 2.13 (95% CI: 0.75-3.51) at age 75 years (P interaction = 0.008). Improvement in SAQ Angina Frequency was less dependent on age (P interaction = 0.08). There were no age differences between invasive vs conservative management on the composite clinical outcome (P interaction = 0.29). Older patients with chronic coronary disease and moderate or severe ischemia had consistent improvement in angina frequency but less improvement in angina-related health status with invasive management compared with younger patients. Invasive management was not associated with improved clinical outcomes in older or younger patients. (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches [ISCHEMIA]; NCT01471522) [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. TCT-480 Outcomes in Patients with Non-obstructive Coronary Artery Disease With and Without Cardiac Biomarker Elevations: The ACUITY Trial
- Author
-
Newman, Jonathan, Dangas, George, Brener, Sorin, Xu, Ke, Genereux, Philippe, Lansky, Alexandra, Nikolsky, Eugenia, Mehran, Roxana, and Stone, Gregg
- Published
- 2012
- Full Text
- View/download PDF
46. Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial.
- Author
-
Garcia, R. Angel, Spertus, John A., Benton, Mary C., Jones, Philip G., Mark, Daniel B., Newman, Jonathan D., Bangalore, Sripal, Boden, William E., Stone, Gregg W., Reynolds, Harmony R., Hochman, Judith S., Maron, David J., and ISCHEMIA Research Group
- Subjects
- *
PATIENT compliance , *ISCHEMIA , *CORONARY disease , *CONSERVATIVE treatment , *CHRONIC diseases , *RESEARCH , *RESEARCH methodology , *HEALTH status indicators , *EVALUATION research , *COMPARATIVE studies , *RANDOMIZED controlled trials , *DRUGS , *QUESTIONNAIRES , *PROBABILITY theory - Abstract
Background: The ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) trial randomized participants with chronic coronary disease (CCD) to guideline-directed medical therapy with or without angiography and revascularization. The study examined the association of nonadherence with health status outcomes.Objectives: The study sought to compare 12-month health status outcomes of adherent and nonadherent participants with CCD with an a priori hypothesis that nonadherent patients would have better health status if randomized to invasive management.Methods: Self-reported medication-taking behavior was assessed at randomization with a modified 4-item Morisky-Green-Levine Adherence Scale, and participants were classified as adherent or nonadherent. Twelve-month health status was assessed with the 7-item Seattle Angina Questionnaire (SAQ-7) summary score (SS), which ranges from 0 to 100 (higher score = better). The association of adherence with outcomes was evaluated using Bayesian proportional odds models, including an interaction by study arm (conservative vs invasive).Results: Among 4,480 randomized participants, 1,245 (27.8%) were nonadherent at baseline. Nonadherent participants had worse baseline SAQ-7 SS in both conservative (72.9 ± 19.3 vs 75.6 ± 18.4) and invasive (71.0 ± 19.8 vs 74.2 ± 18.7) arms. In adjusted analyses, adherence was associated with higher 12-month SAQ-7 SS in both treatment groups (mean difference in SAQ-7 SS with conservative treatment = 1.6 [95% credible interval: 0.3-2.9] vs with invasive management = 1.9 [95% credible interval: 0.8-3.1]), with no interaction by treatment.Conclusions: More than 1 in 4 participants reported medication nonadherence, which was associated with worse health status in both conservative and invasive treatment strategies at baseline and 12 months. Strategies to improve medication adherence are needed to improve health status outcomes in CCD, regardless of treatment strategy. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522). [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
47. Neural ensemble communities: open-source approaches to hardware for large-scale electrophysiology.
- Author
-
Siegle, Joshua H, Hale, Gregory J, Newman, Jonathan P, and Voigts, Jakob
- Subjects
- *
ELECTROPHYSIOLOGY , *NEURAL circuitry , *DATA acquisition systems , *INTEGRATED circuits , *RAPID prototyping , *WEB-based user interfaces - Abstract
One often-overlooked factor when selecting a platform for large-scale electrophysiology is whether or not a particular data acquisition system is ‘open’ or ‘closed’: that is, whether or not the system's schematics and source code are available to end users. Open systems have a reputation for being difficult to acquire, poorly documented, and hard to maintain. With the arrival of more powerful and compact integrated circuits, rapid prototyping services, and web-based tools for collaborative development, these stereotypes must be reconsidered. We discuss some of the reasons why multichannel extracellular electrophysiology could benefit from open-source approaches and describe examples of successful community-driven tool development within this field. In order to promote the adoption of open-source hardware and to reduce the need for redundant development efforts, we advocate a move toward standardized interfaces that connect each element of the data processing pipeline. This will give researchers the flexibility to modify their tools when necessary, while allowing them to continue to benefit from the high-quality products and expertise provided by commercial vendors. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
48. Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial.
- Author
-
Senior, Roxy, Reynolds, Harmony R., Min, James K., Berman, Daniel S., Picard, Michael H., Chaitman, Bernard R., Shaw, Leslee J., Page, Courtney B., Govindan, Sajeev C., Lopez-Sendon, Jose, Peteiro, Jesus, Wander, Gurpreet S., Drozdz, Jaroslaw, Marin-Neto, Jose, Selvanayagam, Joseph B., Newman, Jonathan D., Thuaire, Christophe, Christopher, Johann, Jang, James J., and Kwong, Raymond Y.
- Subjects
- *
CORONARY artery disease , *MYOCARDIAL perfusion imaging , *TAKOTSUBO cardiomyopathy , *CORONARY artery bypass , *STRESS echocardiography , *ISCHEMIA , *RESEARCH , *INTERNATIONAL relations , *PREDICTIVE tests , *RESEARCH methodology , *SELF-evaluation , *EVALUATION research , *COMPARATIVE studies , *RANDOMIZED controlled trials , *HEART function tests , *RESEARCH funding , *CORONARY arteries , *LONGITUDINAL method , *EMISSION-computed tomography , *HEALTH self-care - Abstract
Background: Detection of ≥50% diameter stenosis left main coronary artery disease (LMD) has prognostic and therapeutic implications. Noninvasive stress imaging or an exercise tolerance test (ETT) are the most common methods to detect obstructive coronary artery disease, though stress test markers of LMD remain ill-defined.Objectives: The authors sought to identify markers of LMD as detected on coronary computed tomography angiography (CTA), using clinical and stress testing parameters.Methods: This was a post hoc analysis of ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches), including randomized and nonrandomized participants who had locally determined moderate or severe ischemia on nonimaging ETT, stress nuclear myocardial perfusion imaging, or stress echocardiography followed by CTA to exclude LMD. Stress tests were read by core laboratories. Prior coronary artery bypass grafting was an exclusion. In a stepped multivariate model, the authors identified predictors of LMD, first without and then with stress testing parameters.Results: Among 5,146 participants (mean age 63 years, 74% male), 414 (8%) had LMD. Predictors of LMD were older age (P < 0.001), male sex (P < 0.01), absence of prior myocardial infarction (P < 0.009), transient ischemic dilation of the left ventricle on stress echocardiography (P = 0.05), magnitude of ST-segment depression on ETT (P = 0.004), and peak metabolic equivalents achieved on ETT (P = 0.001). The models were weakly predictive of LMD (C-index 0.643 and 0.684).Conclusions: In patients with moderate or severe ischemia, clinical and stress testing parameters were weakly predictive of LMD on CTA. For most patients with moderate or severe ischemia, anatomical imaging is needed to rule out LMD. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522). [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
49. Bounds for fourth-order [0, 1] difference equations
- Author
-
Berenhaut, Kenneth S., Gibson, Benjamin G., Newman, Jonathan H., and Anderson, Jacob F.
- Subjects
- *
DIFFERENTIAL equations , *COMPUTATIONAL mathematics , *MATRICES (Mathematics) , *ABSTRACT algebra , *FINITE model theory - Abstract
This note examines bounds for fourth-order linear difference equations with coefficients restricted to the unit interval. It is shown that all solutions are of order strictly less than . The bound is shown to be nearly best possible. Applications to zero–one banded matrices are also discussed. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
50. Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.
- Author
-
Wilcox, Tanya, De Block, Christophe, Schwartzbard, Arthur Z, and Newman, Jonathan D
- Subjects
- *
CARDIOVASCULAR disease prevention , *CARDIOVASCULAR diseases , *HYPOGLYCEMIC agents , *TYPE 2 diabetes , *RESEARCH funding , *PHARMACODYNAMICS - Abstract
Given the intersection between diabetes mellitus and cardiovascular disease (CVD), pharmacologic agents used to treat type 2 diabetes mellitus must show cardiovascular safety. Comorbid conditions, including heart failure and chronic kidney disease, are increasingly prevalent in patients with diabetes; therefore, they also play a large role in drug safety. Although biguanides, sulfonylurea, glitazones, and dipeptidyl peptidase 4 inhibitors have variable effects on cardiovascular events, sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists have consistently shown safety and reduction in cardiovascular events in patients with established CVD. These medications are becoming essential tools for cardioprotection for patients with diabetes and CVD. They may also have roles in primary prevention and renal protection. This paper will review the cardiovascular impact, adverse effects, and possible mechanisms of action of pharmacologic agents used to treat patients with type 2 diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.